Key Takeaways Retatrutide is being studied as a triple agonist that targets GIP, GLP-1, and glucagon receptors
Concomitant use with metformin, sulfonylureas, dipeptidyl peptidase-4 (DPP-4) inhibitors, or insulin targets multiple pathways involved in glucose metabolism
Tapering gradually tends to be gentler than stopping all at once
The right approach depends on the individuals medical history, weight trajectory, metabolic risk, side effects, preferences, access, and treatment goals
Its the most comprehensive pocket encyclopedia of plastic surgery terms, before and after photos, and visualization tools to help you really know what to expect from a procedure, including seeing potential results on your own photo